Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats

Peptides

Volumn 19, Issue 2, 1998, Pages 291-299

  Meereis Schwanke, Kerstin ^a   Klonowski Stumpe, Hanne ^a   Herberg, Lieselotte ^b   Niederau, Claus ^a  

^a Division of Gastroenterology   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Caerulein; CCK; CCK antagonists; CCK receptor; Food intake; Gastrin; Leptin; Loxiglumide; Pancreatic growth; Satiety; Zucker rat

Indexed keywords

CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; DNA; LOXIGLUMIDE; PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOOD INTAKE; LEAN BODY WEIGHT; MALE; NONHUMAN; OBESITY; PANCREAS; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; CAERULEIN; CHOLECYSTOKININ; DRUG RESISTANCE; EATING; FEMALE; MALE; OBESITY; ORGAN SIZE; PANCREAS; PROGLUMIDE; RATS; RATS, ZUCKER; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; SATIETY RESPONSE;

ANIMALIA;

EID: 0032006616     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00261-1     Document Type: Article

References (65)

1. Byrkit, S. J. Elements of statistics, Chapter 10: Analysis of variance, 3rd Edition. New York: van Nostrand Company; 1980:305-358.
2. Chang T. M., Chey W. Y. Radioimmunoassay of cholecystokinin. Dig. Dis. Sci. 28:1983;456-468.
3. Cheng C. A., Geoghegan J. G., Lawson D. C., Berlangieri S. U., Akwari O., Pappas T. N. Central and peripheral effects of CCK receptor antagonists on satiety in dogs. Am. J. Physiol. 265:1993;G219-G223.
4. Crawley N. J., Beinfeld M. C. Rapid development of tolerance to the behavioral actions of cholecystokinin. Nature (Lond.). 302:1983;703-706.
5. Della-Fera M. A., Coleman B. D., Baile C. A. CNS-injection of CCK in rats effects on real and sham feeding and gastric emptying . Am. J. Physiol. 258:1990;R1165-R1169.
6. Dourish C. T., Rycroft W., Iversen S. D. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science (Washington DC). 245:1989;1509-1511.
7. Ebenezer I. S., de la Riva C., Baldwin B. A. Effects of the CCK receptor antagonist MK-329 on food intake in pigs. Physiol. Behav. 47:1990;145-148.
8. Greenberg D., Smith G. P., Gibbs J. Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats. Am. J. Physiol. 252:1987;R1015-R1018.
9. Guan D., Phillips W., Green G. Inhibition of gastric emptying and food intake by exogenous and endogenous CCK role of capsaicin-sensitive vagal afferent pathway . Gastroenterology. 110:1996;A672.
10. Herberg L., Coleman D. L. Laboratory animals exhibiting obesity and diabetes syndrome. Metabolism. 26:1977;59-99.
11. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6:1979;65-70.
12. Hölzer H. H., Turkelson C. M., Solomon T. E., Raybould H. E. Intestinal lipids inhibits gastric emptying via CCK and a vagal capsaicin afferent pathway in rats. Am. J. Physiol. 267:1994;G625-G629.
13. Idia M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Substitution at codon 269 (glutamine → proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 224:1996;597-604.
14. Idia M., Murakami T., Ishida K., Mizuno A., Kuwajima M., Shima K. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 222:1996;19-26.
15. Jansen J. B. M. J., Lamers B. H. H. W. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin. Chim. Acta. 33:1983;2197-2205.
16. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Analyt. Biochem. 102:1990;344-352.
17. Li Y., Owyang C. Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J. Clin. Invest. 92:1993;418-424.
18. Li Y., Hao Y. B., Owyang C. High affinity CCK-A receptors on the vagus mediate cholecystokinin-stimulated pancreatic secretion in the rat. Gastroenterology. 110:1996;A1094.
19. Liberge M., Arruebo M. P., Bueno L. Role of hypothalamic cholecystokinin octapeptide in the colonic motor response to a meal in rats. Gastroenterology. 100:1991;441-449.
20. Liddle R. A., Goldfine I. D., Williams J. A. Bioassay of plasma cholecystokinin in rats effects of food, trypsin inhibitor, and alcohol . Gastroenterology. 87:1984;542-549.
21. Liddle R. A., Goldfine I. D., Rosen M. S., Taplitz R. A., Williams J. A. Cholecystokinin bioactivity in human plasma molecular forms, responses to feeding, and relationship to gallbladder contraction . J. Clin. Invest. 75:1985;1140-1142.
22. Lieverse R. J., Jansen J. B. M. J., Masclee A. A. M., Lamers C. B. H. W. Role of cholecystokinin in the regulation of satiation and satiety in humans. Ann. NY Acad. Sci. 713:1994;268-272.
23. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurements with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Makovec F., Chiste R., Bani M., Pacini M. A., Setnikar I., Rovati L. A. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneim. Forsch. 35:1985;1048-1051.
25. Makovec F., Bani M., Chistè R., Revel L., Rovati L. C., Setnikar I. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats. Reg. Pept. 16:1986;281-290.
26. McLaughlin C. L., Baile C. A. Decreased sensitivity of Zucker obese rats to the putative satiety agent cholecystokinin. Physiol. Behav. 25:1980;543-548.
27. McLaughlin C. L., Baile C. A. Serum insulin, glucose and triglyceride responses of Zucker obese and lean rats to cholecystokinin. Physiol. Behav. 26:1981;995-999.
28. McLaughlin C. L., Peikin S. R., Baile C. A. Food intake response to modulation of secretion of cholecystokinin in Zucker rats. Am. J. Physiol. 244:1983;R676-R685.
29. McLaughlin C. L., Baile C. A., Buonomo F. C. Effect of CCK antibodies on food intake and weight gain in Zucker rats. Physiol. Behav. 34:1985;277-282.
30. McLaughlin C. L., Baile C. A., Della-Fera M. A. Changes in brain CCK concentration with peripheral CCK injections in Zucker rats. Physiol. Behav. 36:1986;477-482.
31. McLaughlin C. L., Baile C. A., Della-Fera M. A. Changes in brain met-enkephalin concentrations with peripheral CCK injections in Zucker rats. Physiol. Behav. 36:1986;681-686.
32. Micevych P. E., Go V. L. W., Yaksh T. L. In vitro release of cholecystokinin from hypothalamus and frontal cortex of Sprague-Dawley, Zucker lean (Fa/-) and obese (fa/fa) rats. Peptides. 5:1984;73-80.
33. Niederau C., Niederau M., Williams J. A., Grendell J. H. New proglumide analogue CCK-receptor antagonists very potent and selective for peripheral tissues . Am. J. Physiol. 251:1986;G856-G860.
34. Niederau C., Liddle R. A., Williams J. A., Grendell J. H. Pancreatic growth Interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice . Gut. 28:1987;63-69.
35. Niederau C., Heintges T., Rovati L., Strohmeyer G. Effects of loxiglumide on gallbladder emptying in healthy volunteers. Gastroenterology. 97:1989;1331-1336.
36. Niederau M., Niederau C., Strohmeyer G., Grendell J. H. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Am. J. Physiol. 56:1989;G150-G157.
37. Niederau C., Lüthen R., Niederau M., Strohmeyer G., Ferrell L. D., Grendell J. H. Long-term effects of stimulation and inhibition at the CCK-receptor on morphology, function and growth of pancreas and intestine. Digestion. 46:1990;217-225.
38. Niederau C., Karaus M. Effects of agonists and antagonists of cholecystokinin on contractile and myoelectric activity of isolated muscle of colon and ileum in the dog and guinea pig. J. Gastrointest. Motility. 2:1990;160-175.
39. Niederau C., Karaus M. Effects of CCK-receptor blockade on intestinal motor activity in conscious dogs. Am. J. Physiol. 260:1991;G315-G324.
40. Niederau C., Schwarzendrube J., Lüthen R., Strohmeyer G. The effects of a CCK-receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. Pancreas. 7:1992;1-10.
41. Niederau C., Mecklenbeck W., Heintges T., Lüthen R. CCK does not delay gastric emptying of regular meals in humans. Hepatogastroenterol. 40:1993;380-383.
42. Niederau C., Heintges T., Lüthen R. The effects of CCK on pancreatic function and morphology. Ann. NY Acad. Sci. 713:1994;180-196.
43. Niederau, C.; Meereis-Schwanke, K.; Klonowski-Stumpe, H.; Herberg, L. CCK-resistance in Zucker obese vs. lean rats. Reg. Pept. 1997; 70:97-104.
44. Orosco M., Duche J. C., Rybarczyk M. C., Rouch C., Cohen Y., Jacquot C. Variability of changes in obese rat brain monoamines in response to cholecystokinin. Gen. Pharma. 17:1986;665-669.
45. Raybould H. E., Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin sensitive vagal pathway in rats. Am. J. Physiol. 255:1988;G242-G246.
46. Reidelberger R. D., Solomon T. E. Comparative effects of CCK-8 on feeding, sham feeding and exocrine pancreatic secretion in rats. Am. J. Physiol. 251:1986;R1512-R1518.
47. Ritter R. C., Brenner L. A., Tamura C. S. Endogenous CCK and the peripheral neutral substrates of intestinal satiety. Ann. NY Acad. Sci. 713:1994;255-267.
48. Rodbell M. Localization of lipoprotein lipase in fat cells of rat adipose tissue. J. Biol. Chem. 239:1964;385-391.
49. Smith E. B., Slater R. S. The microdissection of large atherosclerotic plaque to give morphologically and topographically defined fraction for analysis. Atherosclerosis. 15:1972;57-69.
50. Smith G. P., Gibbs J. Satiating effect of cholecystokinin. Ann. NY Acad. Sci. 713:1994;236-241.
51. Schick R. R., Reilly W. M., Roddy D. R., Yaksh T. L., Go V. W. L. Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain. Res. 418:1987;20-26.
52. Schick R. R., Schusdziarra V., Yaksh T. L., Go V. L. W. Brain regions where cholecystokinin exerts its effect on satiety. Ann. NY Acad. Sci. 713:1994;242-254.
53. Schneider, L. H.; Murphy, R. B.; Gibbs, J.; Smith, G. P. Comparative potencies of CCK antagonists for the reversal of the satiating effects of cholecystokinin. In: Wang, R. A.; Schoenfeld, R., Eds. Cholecystokinin receptors antagonists. New York: Alan R. Liss Inc.; 1994; 263-284.
54. Schwartz G. J., McHugh P. R., Moran T. H. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents. Am. J. Physiol. 267:1994;R303-R308.
55. Schwartz G. J., McHugh P. R., Moran T. H. Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. Am. J. Physiol. 261:1991;R64-R69.
56. Setnikar I., Bani M., Cereda R., Chiste R., Makovec F., Pacini A., Revel L., Rovati L. C., Rovati L. A. Pharmacological characterization of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneim. Forsch. 6:1987;703-707.
57. South E., Ritter R. C. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides. 9:1988;601-612.
58. Strohmayer A. J., Greenberg D. Devazepide alters meal patterns in lean, but not obese, male Zucker rats. Physiol. Behav. 56:1994;1037-1039.
59. Strohmayer A. J., Greenberg D. Devazepide increases food intake in male but not female Zucker rats. Physiol. Behav. 60:1996;273-275.
60. Takaya K., Ogawa Y., Isse N., Okazaki T., Satoh N., Masuzaki H., Mori K., Tamura N., Hosoda K., Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs - identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Comm. 225:1996;75-83.
61. Wank A., Pisegna R., de Weerth A. Cholecystokinin receptor family Molecular cloning, structure, and functional expression in rat, guinea pig, and human . Ann. NY Acad. Sci. 713:1994;49-66.
62. Weatherford S. C., Laughton W. B., Salabarria J., Danho W. D., Tilley J. W., Netrerville L. A., Schwarzt G. J., Moran T. H. CCK satiety is differentially mediated by high and low-affinity CCK receptors in mice and rats. Am. J. Physiol. 264:1993;R244-R249.
63. Wiener I., Inoue K., Fagan C. J., Lilja P., Watson L. C., Thompson J. C. Release of cholecystokinin in man correlation of blood levels with gallbladder contraction . Ann. Surg. 194:1981;321-327.
64. Williams J. A. Cholecystokinin a hormone and a neurotransmitter . Biomed. Res. 3:1982;107-115.
65. Yok D. P., Brenner L., Ritter R. C. CCK-receptors antagonists attenuate suppression of sham feeding by intestinal nutrients. Am. J. Physiol. 262:1992;R554-R561.